LAC Med Berhad (KLSE:LACMED)
Malaysia · Delayed Price · Currency is MYR 0.7200
0.00 (0.00%)
At close: Sep 21, 2026
LAC Med Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 181.67 | 201.66 | 183.22 | 150.35 | 106.64 | |
Revenue Growth | -4.08% | 10.06% | 21.86% | 40.98% | - |
Cost of Revenue | 131.3 | 143.08 | 137.74 | 109.32 | 76.88 |
Gross Profit | 50.37 | 58.57 | 45.48 | 41.03 | 29.77 |
Selling, General & Admin | 25.72 | 27 | 17.86 | 16.57 | 10.07 |
Other Operating Expenses | 0.68 | 0.4 | 0.35 | 0.25 | 0.19 |
Operating Expenses | 25.75 | 28.06 | 18.53 | 14.71 | 11.81 |
Operating Income | 24.62 | 30.51 | 26.95 | 26.32 | 17.96 |
Interest Expense | -1.15 | -0.77 | -0.49 | -1.01 | -0.83 |
Interest & Investment Income | - | - | - | 0.19 | 0.21 |
Currency Exchange Gain (Loss) | 0.06 | - | - | 0.14 | - |
Other Non Operating Income (Expenses) | 1.64 | 1.25 | 0.59 | 0.06 | -0.16 |
Pretax Income | 25.17 | 31 | 27.04 | 25.7 | 17.18 |
Income Tax Expense | 7.03 | 9.07 | 6.65 | 4.95 | 4.11 |
Earnings From Continuing Operations | 18.13 | 21.92 | 20.4 | 20.74 | 13.06 |
Minority Interest in Earnings | 0.08 | 0.06 | 0 | - | - |
Net Income | 18.21 | 21.99 | 20.4 | 20.74 | 13.06 |
Net Income to Common | 18.21 | 21.99 | 20.4 | 20.74 | 13.06 |
Net Income Growth | -4.83% | 7.78% | -1.66% | 58.78% | - |
Shares Outstanding (Basic) | 117 | 117 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 117 | 117 | 2 | 2 | 2 |
Shares Change | -41.96% | 5726.57% | - | - | - |
EPS (Basic) | 0.16 | 0.19 | 10.20 | 10.37 | 6.53 |
EPS (Diluted) | 0.16 | 0.19 | 10.20 | 10.37 | 6.53 |
EPS Growth | 63.84% | -98.15% | -1.65% | 58.81% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -34.26 | -9.09 | 30.17 | 21.72 | 2.65 |
Free Cash Flow Per Share | -0.29 | -0.08 | 15.09 | 10.86 | 1.32 |
Dividend Per Share | 0.006 | 0.006 | - | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 27.73% | 29.05% | 24.82% | 27.29% | 27.91% |
Operating Margin | 13.55% | 15.13% | 14.71% | 17.51% | 16.84% |
Profit Margin | 10.02% | 10.90% | 11.13% | 13.80% | 12.25% |
Free Cash Flow Margin | -18.86% | -4.51% | 16.47% | 14.45% | 2.48% |
EBITDA | 27.05 | 31.65 | 27.25 | 26.54 | 18.09 |
EBITDA Margin | 14.89% | 15.70% | 14.87% | 17.66% | 16.96% |
D&A For EBITDA | 2.43 | 1.14 | 0.31 | 0.22 | 0.12 |
EBIT | 24.62 | 30.51 | 26.95 | 26.32 | 17.96 |
EBIT Margin | 13.55% | 15.13% | 14.71% | 17.51% | 16.84% |
Effective Tax Rate | 27.95% | 29.27% | 24.58% | 19.27% | 23.95% |